VELTASSA (Relypsa, Inc.)
Welcome to the PulseAid listing for the VELTASSA drug offered from Relypsa, Inc.. This Potassium Binder [EPC],Potassium Ion Binding Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Relypsa, Inc. |
NON-PROPRIETARY NAME: | patiromer |
SUBSTANCE NAME: | PATIROMER |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Potassium Binder [EPC],Potassium Ion Binding Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | POWDER, FOR SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-10-23 |
END MARKETING DATE: | 0000-00-00 |
VELTASSA HUMAN PRESCRIPTION DRUG Details:
Item Description | VELTASSA from Relypsa, Inc. |
LABELER NAME: | Relypsa, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.4(g/1) |
START MARKETING DATE: | 2015-10-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53436-084_889a47fe-9cc1-49dd-b97c-63b328399eaa |
PRODUCT NDC: | 53436-084 |
APPLICATION NUMBER: | NDA205739 |
Other PATIROMER Pharmaceutical Manufacturers / Labelers: